Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yang-Xin Fu

Showing results (191-200 of 337) with videos related to

Pageof 34
Sort By:
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 16, 2012
Radiation-inducible immunotherapy for cancer: senescent tumor cells as a cancer vaccineYuru Meng, Elena V Efimova, Khaled W Hamzeh, et al.
JCI Insight|April 10, 2020
Targeting tumors with IL-21 reshapes the tumor microenvironment by proliferating PD-1intTim-3-CD8+ T cellsSisi Deng, Zhichen Sun, Jian Qiao, et al.
Cell Reports|August 23, 2018
Dual Targeting of Innate and Adaptive Checkpoints on Tumor Cells Limits Immune EvasionXiaojuan Liu, Longchao Liu, Zhenhua Ren, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 17, 2015
Intratumoral Delivery of IL-21 Overcomes Anti-Her2/Neu Resistance through Shifting Tumor-Associated Macrophages from M2 to M1 PhenotypeMeng Xu, Mingyue Liu, Xuexiang Du, et al.
Nature Medicine|September 1, 2015
CD47 blockade triggers T cell-mediated destruction of immunogenic tumorsXiaojuan Liu, Yang Pu, Kyle Cron, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 4, 2016
Clearing Persistent Extracellular Antigen of Hepatitis B Virus: An Immunomodulatory Strategy To Reverse Tolerance for an Effective Therapeutic VaccinationDanming Zhu, Longchao Liu, Dan Yang, et al.
Science Translational Medicine|January 28, 2021
A chimeric antigen receptor with antigen-independent OX40 signaling mediates potent antitumor activityHuihui Zhang, Fanlin Li, Jiang Cao, et al.
The Journal of Experimental Medicine|June 18, 2003
B7DC/PDL2 promotes tumor immunity by a PD-1-independent mechanismXingluo Liu, Jian Xin Gao, Jing Wen, et al.
Nature Communications|September 25, 2020
PD-L1 on dendritic cells attenuates T cell activation and regulates response to immune checkpoint blockadeQi Peng, Xiangyan Qiu, Zihan Zhang, et al.
Journal of Clinical Medicine|July 27, 2022
A Heterologous V-01 or Variant-Matched Bivalent V-01D-351 Booster following Primary Series of Inactivated Vaccine Enhances the Neutralizing Capacity against SARS-CoV-2 Delta and Omicron StrainsZhiren Zhang, Qiaren He, Wei Zhao, et al.
Pageof 34

Showing results (191-200 of 337) with videos related to

Sort By:
Pageof 34
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 16, 2012
Radiation-inducible immunotherapy for cancer: senescent tumor cells as a cancer vaccineYuru Meng, Elena V Efimova, Khaled W Hamzeh, et al.
JCI Insight|April 10, 2020
Targeting tumors with IL-21 reshapes the tumor microenvironment by proliferating PD-1intTim-3-CD8+ T cellsSisi Deng, Zhichen Sun, Jian Qiao, et al.
Cell Reports|August 23, 2018
Dual Targeting of Innate and Adaptive Checkpoints on Tumor Cells Limits Immune EvasionXiaojuan Liu, Longchao Liu, Zhenhua Ren, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 17, 2015
Intratumoral Delivery of IL-21 Overcomes Anti-Her2/Neu Resistance through Shifting Tumor-Associated Macrophages from M2 to M1 PhenotypeMeng Xu, Mingyue Liu, Xuexiang Du, et al.
Nature Medicine|September 1, 2015
CD47 blockade triggers T cell-mediated destruction of immunogenic tumorsXiaojuan Liu, Yang Pu, Kyle Cron, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 4, 2016
Clearing Persistent Extracellular Antigen of Hepatitis B Virus: An Immunomodulatory Strategy To Reverse Tolerance for an Effective Therapeutic VaccinationDanming Zhu, Longchao Liu, Dan Yang, et al.
Science Translational Medicine|January 28, 2021
A chimeric antigen receptor with antigen-independent OX40 signaling mediates potent antitumor activityHuihui Zhang, Fanlin Li, Jiang Cao, et al.
The Journal of Experimental Medicine|June 18, 2003
B7DC/PDL2 promotes tumor immunity by a PD-1-independent mechanismXingluo Liu, Jian Xin Gao, Jing Wen, et al.
Nature Communications|September 25, 2020
PD-L1 on dendritic cells attenuates T cell activation and regulates response to immune checkpoint blockadeQi Peng, Xiangyan Qiu, Zihan Zhang, et al.
Journal of Clinical Medicine|July 27, 2022
A Heterologous V-01 or Variant-Matched Bivalent V-01D-351 Booster following Primary Series of Inactivated Vaccine Enhances the Neutralizing Capacity against SARS-CoV-2 Delta and Omicron StrainsZhiren Zhang, Qiaren He, Wei Zhao, et al.
Pageof 34